Canine Heart Disease Welfare: DCM, MVD, and Quality-of-Life Management

Heart disease is one of the leading causes of death in dogs, with myxomatous mitral valve disease (MVD) affecting small breeds and dilated cardiomyopathy (DCM) affecting large breeds. Modern veterinary cardiology offers life-extending treatments that significantly improve welfare for affected dogs.

Key Facts

MVD affects over 80% of Cavalier King Charles spaniels by age 10 — the highest breed prevalence of any cardiac condition
DCM is most common in Dobermanns, Great Danes, Irish wolfhounds, and boxers, often with sudden cardiac death
The EPIC trial demonstrated that pimobendan started at preclinical Stage B2 MVD extends time to heart failure by 15 months
Veterinary cardiologist assessment including echocardiography is required to stage and manage cardiac disease properly
Dobermann DCM can cause sudden cardiac death at subclinical stages — Holter monitor screening is essential in this breed

Welfare Considerations

Dogs in early-stage cardiac disease (Stage B2) have no clinical signs but are at risk of progression; starting pimobendan at this stage is now evidence-based welfare practice that delays suffering. Dogs in overt heart failure (Stage C/D) experience exercise intolerance, breathlessness, and fatigue that limits activity and quality of life. Cough from pulmonary oedema causes distress. With appropriate diuretic and pimobendan therapy, dogs in heart failure can maintain good quality of life for months to over a year. Welfare assessment using validated scales like the Minnesota Living with Heart Failure tool adapted for dogs provides objective quality-of-life tracking. End-of-life decisions should be proactive — before respiratory distress becomes severe.

What You Can Do

Arrange annual heart auscultation for breeds at high cardiac risk including Cavaliers and Dobermanns
Pursue echocardiography with a veterinary cardiologist once a cardiac murmur is detected
Start pimobendan when your cardiologist identifies Stage B2 criteria — the evidence supports early treatment
Monitor respiratory rate at rest daily using apps that detect early fluid accumulation before crisis
Discuss quality-of-life assessment and euthanasia timing proactively with your cardiologist